Global Gastrointestinal Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
This report provides a deep insight into the global Gastrointestinal Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Therapeutics market in any manner.
Global Gastrointestinal Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
Market Segmentation (by Type)
Oral
Parenteral
Market Segmentation (by Application)
IBD
Irritable Bowel Syndrome (IBS)
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
This report provides a deep insight into the global Gastrointestinal Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Therapeutics market in any manner.
Global Gastrointestinal Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
Market Segmentation (by Type)
Oral
Parenteral
Market Segmentation (by Application)
IBD
Irritable Bowel Syndrome (IBS)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gastrointestinal Therapeutics Market
- Overview of the regional outlook of the Gastrointestinal Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gastrointestinal Therapeutics
1.2 Key Market Segments
1.2.1 Gastrointestinal Therapeutics Segment by Type
1.2.2 Gastrointestinal Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gastrointestinal Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Gastrointestinal Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Gastrointestinal Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastrointestinal Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastrointestinal Therapeutics Sales Sites, Area Served, Product Type
3.6 Gastrointestinal Therapeutics Market Competitive Situation and Trends
3.6.1 Gastrointestinal Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastrointestinal Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GASTROINTESTINAL THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Gastrointestinal Therapeutics Price by Type (2019-2024)
7 GASTROINTESTINAL THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Therapeutics Market Sales by Application (2019-2024)
7.3 Global Gastrointestinal Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Gastrointestinal Therapeutics Sales Growth Rate by Application (2019-2024)
8 GASTROINTESTINAL THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Gastrointestinal Therapeutics Sales by Region
8.1.1 Global Gastrointestinal Therapeutics Sales by Region
8.1.2 Global Gastrointestinal Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Gastrointestinal Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastrointestinal Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastrointestinal Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastrointestinal Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastrointestinal Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AbbVie
9.1.1 AbbVie Gastrointestinal Therapeutics Basic Information
9.1.2 AbbVie Gastrointestinal Therapeutics Product Overview
9.1.3 AbbVie Gastrointestinal Therapeutics Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Gastrointestinal Therapeutics SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 Allergan
9.2.1 Allergan Gastrointestinal Therapeutics Basic Information
9.2.2 Allergan Gastrointestinal Therapeutics Product Overview
9.2.3 Allergan Gastrointestinal Therapeutics Product Market Performance
9.2.4 Allergan Business Overview
9.2.5 Allergan Gastrointestinal Therapeutics SWOT Analysis
9.2.6 Allergan Recent Developments
9.3 Johnson and Johnson
9.3.1 Johnson and Johnson Gastrointestinal Therapeutics Basic Information
9.3.2 Johnson and Johnson Gastrointestinal Therapeutics Product Overview
9.3.3 Johnson and Johnson Gastrointestinal Therapeutics Product Market Performance
9.3.4 Johnson and Johnson Gastrointestinal Therapeutics SWOT Analysis
9.3.5 Johnson and Johnson Business Overview
9.3.6 Johnson and Johnson Recent Developments
9.4 Takeda
9.4.1 Takeda Gastrointestinal Therapeutics Basic Information
9.4.2 Takeda Gastrointestinal Therapeutics Product Overview
9.4.3 Takeda Gastrointestinal Therapeutics Product Market Performance
9.4.4 Takeda Business Overview
9.4.5 Takeda Recent Developments
9.5 Novartis
9.5.1 Novartis Gastrointestinal Therapeutics Basic Information
9.5.2 Novartis Gastrointestinal Therapeutics Product Overview
9.5.3 Novartis Gastrointestinal Therapeutics Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Pfizer
9.6.1 Pfizer Gastrointestinal Therapeutics Basic Information
9.6.2 Pfizer Gastrointestinal Therapeutics Product Overview
9.6.3 Pfizer Gastrointestinal Therapeutics Product Market Performance
9.6.4 Pfizer Business Overview
9.6.5 Pfizer Recent Developments
9.7 Merck
9.7.1 Merck Gastrointestinal Therapeutics Basic Information
9.7.2 Merck Gastrointestinal Therapeutics Product Overview
9.7.3 Merck Gastrointestinal Therapeutics Product Market Performance
9.7.4 Merck Business Overview
9.7.5 Merck Recent Developments
9.8 F. Hoffmann-La Roche
9.8.1 F. Hoffmann-La Roche Gastrointestinal Therapeutics Basic Information
9.8.2 F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Overview
9.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Market Performance
9.8.4 F. Hoffmann-La Roche Business Overview
9.8.5 F. Hoffmann-La Roche Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly Gastrointestinal Therapeutics Basic Information
9.9.2 Eli Lilly Gastrointestinal Therapeutics Product Overview
9.9.3 Eli Lilly Gastrointestinal Therapeutics Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 AstraZeneca
9.10.1 AstraZeneca Gastrointestinal Therapeutics Basic Information
9.10.2 AstraZeneca Gastrointestinal Therapeutics Product Overview
9.10.3 AstraZeneca Gastrointestinal Therapeutics Product Market Performance
9.10.4 AstraZeneca Business Overview
9.10.5 AstraZeneca Recent Developments
9.11 Procter and Gamble
9.11.1 Procter and Gamble Gastrointestinal Therapeutics Basic Information
9.11.2 Procter and Gamble Gastrointestinal Therapeutics Product Overview
9.11.3 Procter and Gamble Gastrointestinal Therapeutics Product Market Performance
9.11.4 Procter and Gamble Business Overview
9.11.5 Procter and Gamble Recent Developments
9.12 Tillotts Pharma
9.12.1 Tillotts Pharma Gastrointestinal Therapeutics Basic Information
9.12.2 Tillotts Pharma Gastrointestinal Therapeutics Product Overview
9.12.3 Tillotts Pharma Gastrointestinal Therapeutics Product Market Performance
9.12.4 Tillotts Pharma Business Overview
9.12.5 Tillotts Pharma Recent Developments
9.13 Takeda
9.13.1 Takeda Gastrointestinal Therapeutics Basic Information
9.13.2 Takeda Gastrointestinal Therapeutics Product Overview
9.13.3 Takeda Gastrointestinal Therapeutics Product Market Performance
9.13.4 Takeda Business Overview
9.13.5 Takeda Recent Developments
9.14 GlaxoSmithKline
9.14.1 GlaxoSmithKline Gastrointestinal Therapeutics Basic Information
9.14.2 GlaxoSmithKline Gastrointestinal Therapeutics Product Overview
9.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Product Market Performance
9.14.4 GlaxoSmithKline Business Overview
9.14.5 GlaxoSmithKline Recent Developments
9.15 Amgen
9.15.1 Amgen Gastrointestinal Therapeutics Basic Information
9.15.2 Amgen Gastrointestinal Therapeutics Product Overview
9.15.3 Amgen Gastrointestinal Therapeutics Product Market Performance
9.15.4 Amgen Business Overview
9.15.5 Amgen Recent Developments
10 GASTROINTESTINAL THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Gastrointestinal Therapeutics Market Size Forecast
10.2 Global Gastrointestinal Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gastrointestinal Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Gastrointestinal Therapeutics Market Size Forecast by Region
10.2.4 South America Gastrointestinal Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gastrointestinal Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gastrointestinal Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gastrointestinal Therapeutics by Type (2025-2030)
11.1.2 Global Gastrointestinal Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gastrointestinal Therapeutics by Type (2025-2030)
11.2 Global Gastrointestinal Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Gastrointestinal Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Gastrointestinal Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gastrointestinal Therapeutics
1.2 Key Market Segments
1.2.1 Gastrointestinal Therapeutics Segment by Type
1.2.2 Gastrointestinal Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gastrointestinal Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Gastrointestinal Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Gastrointestinal Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastrointestinal Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastrointestinal Therapeutics Sales Sites, Area Served, Product Type
3.6 Gastrointestinal Therapeutics Market Competitive Situation and Trends
3.6.1 Gastrointestinal Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastrointestinal Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GASTROINTESTINAL THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Gastrointestinal Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Gastrointestinal Therapeutics Price by Type (2019-2024)
7 GASTROINTESTINAL THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Therapeutics Market Sales by Application (2019-2024)
7.3 Global Gastrointestinal Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Gastrointestinal Therapeutics Sales Growth Rate by Application (2019-2024)
8 GASTROINTESTINAL THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Gastrointestinal Therapeutics Sales by Region
8.1.1 Global Gastrointestinal Therapeutics Sales by Region
8.1.2 Global Gastrointestinal Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Gastrointestinal Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastrointestinal Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastrointestinal Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastrointestinal Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastrointestinal Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AbbVie
9.1.1 AbbVie Gastrointestinal Therapeutics Basic Information
9.1.2 AbbVie Gastrointestinal Therapeutics Product Overview
9.1.3 AbbVie Gastrointestinal Therapeutics Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Gastrointestinal Therapeutics SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 Allergan
9.2.1 Allergan Gastrointestinal Therapeutics Basic Information
9.2.2 Allergan Gastrointestinal Therapeutics Product Overview
9.2.3 Allergan Gastrointestinal Therapeutics Product Market Performance
9.2.4 Allergan Business Overview
9.2.5 Allergan Gastrointestinal Therapeutics SWOT Analysis
9.2.6 Allergan Recent Developments
9.3 Johnson and Johnson
9.3.1 Johnson and Johnson Gastrointestinal Therapeutics Basic Information
9.3.2 Johnson and Johnson Gastrointestinal Therapeutics Product Overview
9.3.3 Johnson and Johnson Gastrointestinal Therapeutics Product Market Performance
9.3.4 Johnson and Johnson Gastrointestinal Therapeutics SWOT Analysis
9.3.5 Johnson and Johnson Business Overview
9.3.6 Johnson and Johnson Recent Developments
9.4 Takeda
9.4.1 Takeda Gastrointestinal Therapeutics Basic Information
9.4.2 Takeda Gastrointestinal Therapeutics Product Overview
9.4.3 Takeda Gastrointestinal Therapeutics Product Market Performance
9.4.4 Takeda Business Overview
9.4.5 Takeda Recent Developments
9.5 Novartis
9.5.1 Novartis Gastrointestinal Therapeutics Basic Information
9.5.2 Novartis Gastrointestinal Therapeutics Product Overview
9.5.3 Novartis Gastrointestinal Therapeutics Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Pfizer
9.6.1 Pfizer Gastrointestinal Therapeutics Basic Information
9.6.2 Pfizer Gastrointestinal Therapeutics Product Overview
9.6.3 Pfizer Gastrointestinal Therapeutics Product Market Performance
9.6.4 Pfizer Business Overview
9.6.5 Pfizer Recent Developments
9.7 Merck
9.7.1 Merck Gastrointestinal Therapeutics Basic Information
9.7.2 Merck Gastrointestinal Therapeutics Product Overview
9.7.3 Merck Gastrointestinal Therapeutics Product Market Performance
9.7.4 Merck Business Overview
9.7.5 Merck Recent Developments
9.8 F. Hoffmann-La Roche
9.8.1 F. Hoffmann-La Roche Gastrointestinal Therapeutics Basic Information
9.8.2 F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Overview
9.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Market Performance
9.8.4 F. Hoffmann-La Roche Business Overview
9.8.5 F. Hoffmann-La Roche Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly Gastrointestinal Therapeutics Basic Information
9.9.2 Eli Lilly Gastrointestinal Therapeutics Product Overview
9.9.3 Eli Lilly Gastrointestinal Therapeutics Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 AstraZeneca
9.10.1 AstraZeneca Gastrointestinal Therapeutics Basic Information
9.10.2 AstraZeneca Gastrointestinal Therapeutics Product Overview
9.10.3 AstraZeneca Gastrointestinal Therapeutics Product Market Performance
9.10.4 AstraZeneca Business Overview
9.10.5 AstraZeneca Recent Developments
9.11 Procter and Gamble
9.11.1 Procter and Gamble Gastrointestinal Therapeutics Basic Information
9.11.2 Procter and Gamble Gastrointestinal Therapeutics Product Overview
9.11.3 Procter and Gamble Gastrointestinal Therapeutics Product Market Performance
9.11.4 Procter and Gamble Business Overview
9.11.5 Procter and Gamble Recent Developments
9.12 Tillotts Pharma
9.12.1 Tillotts Pharma Gastrointestinal Therapeutics Basic Information
9.12.2 Tillotts Pharma Gastrointestinal Therapeutics Product Overview
9.12.3 Tillotts Pharma Gastrointestinal Therapeutics Product Market Performance
9.12.4 Tillotts Pharma Business Overview
9.12.5 Tillotts Pharma Recent Developments
9.13 Takeda
9.13.1 Takeda Gastrointestinal Therapeutics Basic Information
9.13.2 Takeda Gastrointestinal Therapeutics Product Overview
9.13.3 Takeda Gastrointestinal Therapeutics Product Market Performance
9.13.4 Takeda Business Overview
9.13.5 Takeda Recent Developments
9.14 GlaxoSmithKline
9.14.1 GlaxoSmithKline Gastrointestinal Therapeutics Basic Information
9.14.2 GlaxoSmithKline Gastrointestinal Therapeutics Product Overview
9.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Product Market Performance
9.14.4 GlaxoSmithKline Business Overview
9.14.5 GlaxoSmithKline Recent Developments
9.15 Amgen
9.15.1 Amgen Gastrointestinal Therapeutics Basic Information
9.15.2 Amgen Gastrointestinal Therapeutics Product Overview
9.15.3 Amgen Gastrointestinal Therapeutics Product Market Performance
9.15.4 Amgen Business Overview
9.15.5 Amgen Recent Developments
10 GASTROINTESTINAL THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Gastrointestinal Therapeutics Market Size Forecast
10.2 Global Gastrointestinal Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gastrointestinal Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Gastrointestinal Therapeutics Market Size Forecast by Region
10.2.4 South America Gastrointestinal Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gastrointestinal Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gastrointestinal Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gastrointestinal Therapeutics by Type (2025-2030)
11.1.2 Global Gastrointestinal Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gastrointestinal Therapeutics by Type (2025-2030)
11.2 Global Gastrointestinal Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Gastrointestinal Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Gastrointestinal Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gastrointestinal Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastrointestinal Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastrointestinal Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2022)
Table 10. Global Market Gastrointestinal Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastrointestinal Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Gastrointestinal Therapeutics Product Type
Table 13. Global Gastrointestinal Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastrointestinal Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Therapeutics Market Challenges
Table 22. Global Gastrointestinal Therapeutics Sales by Type (K Units)
Table 23. Global Gastrointestinal Therapeutics Market Size by Type (M USD)
Table 24. Global Gastrointestinal Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Gastrointestinal Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Gastrointestinal Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastrointestinal Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Gastrointestinal Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gastrointestinal Therapeutics Sales (K Units) by Application
Table 30. Global Gastrointestinal Therapeutics Market Size by Application
Table 31. Global Gastrointestinal Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Gastrointestinal Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Gastrointestinal Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastrointestinal Therapeutics Market Share by Application (2019-2024)
Table 35. Global Gastrointestinal Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastrointestinal Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Gastrointestinal Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Gastrointestinal Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gastrointestinal Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gastrointestinal Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Gastrointestinal Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gastrointestinal Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. AbbVie Gastrointestinal Therapeutics Basic Information
Table 44. AbbVie Gastrointestinal Therapeutics Product Overview
Table 45. AbbVie Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AbbVie Business Overview
Table 47. AbbVie Gastrointestinal Therapeutics SWOT Analysis
Table 48. AbbVie Recent Developments
Table 49. Allergan Gastrointestinal Therapeutics Basic Information
Table 50. Allergan Gastrointestinal Therapeutics Product Overview
Table 51. Allergan Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Allergan Business Overview
Table 53. Allergan Gastrointestinal Therapeutics SWOT Analysis
Table 54. Allergan Recent Developments
Table 55. Johnson and Johnson Gastrointestinal Therapeutics Basic Information
Table 56. Johnson and Johnson Gastrointestinal Therapeutics Product Overview
Table 57. Johnson and Johnson Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Johnson and Johnson Gastrointestinal Therapeutics SWOT Analysis
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Recent Developments
Table 61. Takeda Gastrointestinal Therapeutics Basic Information
Table 62. Takeda Gastrointestinal Therapeutics Product Overview
Table 63. Takeda Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Takeda Business Overview
Table 65. Takeda Recent Developments
Table 66. Novartis Gastrointestinal Therapeutics Basic Information
Table 67. Novartis Gastrointestinal Therapeutics Product Overview
Table 68. Novartis Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. Pfizer Gastrointestinal Therapeutics Basic Information
Table 72. Pfizer Gastrointestinal Therapeutics Product Overview
Table 73. Pfizer Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Pfizer Business Overview
Table 75. Pfizer Recent Developments
Table 76. Merck Gastrointestinal Therapeutics Basic Information
Table 77. Merck Gastrointestinal Therapeutics Product Overview
Table 78. Merck Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Merck Business Overview
Table 80. Merck Recent Developments
Table 81. F. Hoffmann-La Roche Gastrointestinal Therapeutics Basic Information
Table 82. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Overview
Table 83. F. Hoffmann-La Roche Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. F. Hoffmann-La Roche Business Overview
Table 85. F. Hoffmann-La Roche Recent Developments
Table 86. Eli Lilly Gastrointestinal Therapeutics Basic Information
Table 87. Eli Lilly Gastrointestinal Therapeutics Product Overview
Table 88. Eli Lilly Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Recent Developments
Table 91. AstraZeneca Gastrointestinal Therapeutics Basic Information
Table 92. AstraZeneca Gastrointestinal Therapeutics Product Overview
Table 93. AstraZeneca Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Recent Developments
Table 96. Procter and Gamble Gastrointestinal Therapeutics Basic Information
Table 97. Procter and Gamble Gastrointestinal Therapeutics Product Overview
Table 98. Procter and Gamble Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Procter and Gamble Business Overview
Table 100. Procter and Gamble Recent Developments
Table 101. Tillotts Pharma Gastrointestinal Therapeutics Basic Information
Table 102. Tillotts Pharma Gastrointestinal Therapeutics Product Overview
Table 103. Tillotts Pharma Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Tillotts Pharma Business Overview
Table 105. Tillotts Pharma Recent Developments
Table 106. Takeda Gastrointestinal Therapeutics Basic Information
Table 107. Takeda Gastrointestinal Therapeutics Product Overview
Table 108. Takeda Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Takeda Business Overview
Table 110. Takeda Recent Developments
Table 111. GlaxoSmithKline Gastrointestinal Therapeutics Basic Information
Table 112. GlaxoSmithKline Gastrointestinal Therapeutics Product Overview
Table 113. GlaxoSmithKline Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. GlaxoSmithKline Business Overview
Table 115. GlaxoSmithKline Recent Developments
Table 116. Amgen Gastrointestinal Therapeutics Basic Information
Table 117. Amgen Gastrointestinal Therapeutics Product Overview
Table 118. Amgen Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Amgen Business Overview
Table 120. Amgen Recent Developments
Table 121. Global Gastrointestinal Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Gastrointestinal Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Gastrointestinal Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Gastrointestinal Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Gastrointestinal Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Gastrointestinal Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Gastrointestinal Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Gastrointestinal Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Gastrointestinal Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Gastrointestinal Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Gastrointestinal Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Gastrointestinal Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Gastrointestinal Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Gastrointestinal Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Gastrointestinal Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Gastrointestinal Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Gastrointestinal Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gastrointestinal Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastrointestinal Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastrointestinal Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2022)
Table 10. Global Market Gastrointestinal Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastrointestinal Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Gastrointestinal Therapeutics Product Type
Table 13. Global Gastrointestinal Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastrointestinal Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Therapeutics Market Challenges
Table 22. Global Gastrointestinal Therapeutics Sales by Type (K Units)
Table 23. Global Gastrointestinal Therapeutics Market Size by Type (M USD)
Table 24. Global Gastrointestinal Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Gastrointestinal Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Gastrointestinal Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastrointestinal Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Gastrointestinal Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gastrointestinal Therapeutics Sales (K Units) by Application
Table 30. Global Gastrointestinal Therapeutics Market Size by Application
Table 31. Global Gastrointestinal Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Gastrointestinal Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Gastrointestinal Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastrointestinal Therapeutics Market Share by Application (2019-2024)
Table 35. Global Gastrointestinal Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastrointestinal Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Gastrointestinal Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Gastrointestinal Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gastrointestinal Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gastrointestinal Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Gastrointestinal Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gastrointestinal Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. AbbVie Gastrointestinal Therapeutics Basic Information
Table 44. AbbVie Gastrointestinal Therapeutics Product Overview
Table 45. AbbVie Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AbbVie Business Overview
Table 47. AbbVie Gastrointestinal Therapeutics SWOT Analysis
Table 48. AbbVie Recent Developments
Table 49. Allergan Gastrointestinal Therapeutics Basic Information
Table 50. Allergan Gastrointestinal Therapeutics Product Overview
Table 51. Allergan Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Allergan Business Overview
Table 53. Allergan Gastrointestinal Therapeutics SWOT Analysis
Table 54. Allergan Recent Developments
Table 55. Johnson and Johnson Gastrointestinal Therapeutics Basic Information
Table 56. Johnson and Johnson Gastrointestinal Therapeutics Product Overview
Table 57. Johnson and Johnson Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Johnson and Johnson Gastrointestinal Therapeutics SWOT Analysis
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Recent Developments
Table 61. Takeda Gastrointestinal Therapeutics Basic Information
Table 62. Takeda Gastrointestinal Therapeutics Product Overview
Table 63. Takeda Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Takeda Business Overview
Table 65. Takeda Recent Developments
Table 66. Novartis Gastrointestinal Therapeutics Basic Information
Table 67. Novartis Gastrointestinal Therapeutics Product Overview
Table 68. Novartis Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. Pfizer Gastrointestinal Therapeutics Basic Information
Table 72. Pfizer Gastrointestinal Therapeutics Product Overview
Table 73. Pfizer Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Pfizer Business Overview
Table 75. Pfizer Recent Developments
Table 76. Merck Gastrointestinal Therapeutics Basic Information
Table 77. Merck Gastrointestinal Therapeutics Product Overview
Table 78. Merck Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Merck Business Overview
Table 80. Merck Recent Developments
Table 81. F. Hoffmann-La Roche Gastrointestinal Therapeutics Basic Information
Table 82. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Overview
Table 83. F. Hoffmann-La Roche Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. F. Hoffmann-La Roche Business Overview
Table 85. F. Hoffmann-La Roche Recent Developments
Table 86. Eli Lilly Gastrointestinal Therapeutics Basic Information
Table 87. Eli Lilly Gastrointestinal Therapeutics Product Overview
Table 88. Eli Lilly Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Recent Developments
Table 91. AstraZeneca Gastrointestinal Therapeutics Basic Information
Table 92. AstraZeneca Gastrointestinal Therapeutics Product Overview
Table 93. AstraZeneca Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Recent Developments
Table 96. Procter and Gamble Gastrointestinal Therapeutics Basic Information
Table 97. Procter and Gamble Gastrointestinal Therapeutics Product Overview
Table 98. Procter and Gamble Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Procter and Gamble Business Overview
Table 100. Procter and Gamble Recent Developments
Table 101. Tillotts Pharma Gastrointestinal Therapeutics Basic Information
Table 102. Tillotts Pharma Gastrointestinal Therapeutics Product Overview
Table 103. Tillotts Pharma Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Tillotts Pharma Business Overview
Table 105. Tillotts Pharma Recent Developments
Table 106. Takeda Gastrointestinal Therapeutics Basic Information
Table 107. Takeda Gastrointestinal Therapeutics Product Overview
Table 108. Takeda Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Takeda Business Overview
Table 110. Takeda Recent Developments
Table 111. GlaxoSmithKline Gastrointestinal Therapeutics Basic Information
Table 112. GlaxoSmithKline Gastrointestinal Therapeutics Product Overview
Table 113. GlaxoSmithKline Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. GlaxoSmithKline Business Overview
Table 115. GlaxoSmithKline Recent Developments
Table 116. Amgen Gastrointestinal Therapeutics Basic Information
Table 117. Amgen Gastrointestinal Therapeutics Product Overview
Table 118. Amgen Gastrointestinal Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Amgen Business Overview
Table 120. Amgen Recent Developments
Table 121. Global Gastrointestinal Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Gastrointestinal Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Gastrointestinal Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Gastrointestinal Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Gastrointestinal Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Gastrointestinal Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Gastrointestinal Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Gastrointestinal Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Gastrointestinal Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Gastrointestinal Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Gastrointestinal Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Gastrointestinal Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Gastrointestinal Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Gastrointestinal Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Gastrointestinal Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Gastrointestinal Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Gastrointestinal Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gastrointestinal Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Gastrointestinal Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Gastrointestinal Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Therapeutics Market Size by Country (M USD)
Figure 11. Gastrointestinal Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Gastrointestinal Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastrointestinal Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastrointestinal Therapeutics Market Share by Type
Figure 18. Sales Market Share of Gastrointestinal Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Gastrointestinal Therapeutics by Type in 2023
Figure 20. Market Size Share of Gastrointestinal Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Gastrointestinal Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastrointestinal Therapeutics Market Share by Application
Figure 24. Global Gastrointestinal Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Gastrointestinal Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Gastrointestinal Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Gastrointestinal Therapeutics Market Share by Application in 2023
Figure 28. Global Gastrointestinal Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastrointestinal Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gastrointestinal Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gastrointestinal Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gastrointestinal Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gastrointestinal Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gastrointestinal Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gastrointestinal Therapeutics Sales Market Share by Region in 2023
Figure 44. China Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gastrointestinal Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Gastrointestinal Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gastrointestinal Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gastrointestinal Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gastrointestinal Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gastrointestinal Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastrointestinal Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastrointestinal Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastrointestinal Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Gastrointestinal Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Gastrointestinal Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Gastrointestinal Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Gastrointestinal Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Therapeutics Market Size by Country (M USD)
Figure 11. Gastrointestinal Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Gastrointestinal Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastrointestinal Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastrointestinal Therapeutics Market Share by Type
Figure 18. Sales Market Share of Gastrointestinal Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Gastrointestinal Therapeutics by Type in 2023
Figure 20. Market Size Share of Gastrointestinal Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Gastrointestinal Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastrointestinal Therapeutics Market Share by Application
Figure 24. Global Gastrointestinal Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Gastrointestinal Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Gastrointestinal Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Gastrointestinal Therapeutics Market Share by Application in 2023
Figure 28. Global Gastrointestinal Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastrointestinal Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gastrointestinal Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gastrointestinal Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gastrointestinal Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gastrointestinal Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gastrointestinal Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gastrointestinal Therapeutics Sales Market Share by Region in 2023
Figure 44. China Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gastrointestinal Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Gastrointestinal Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gastrointestinal Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gastrointestinal Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gastrointestinal Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gastrointestinal Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gastrointestinal Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastrointestinal Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastrointestinal Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastrointestinal Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Gastrointestinal Therapeutics Market Share Forecast by Application (2025-2030)
